Proteomic profiling of differentiating osteoblasts

Expert Review of Proteomics

Volumn 3, Issue 5, 2006, Pages 483-496

  Blonder, Josip ^a   Xiao, Zhen ^a   Veenstra, Timothy D ^a  

^a SAIC FREDERICK INC   (United States)

Author keywords

Extracellular matrix mineralization; Osteoblast differentiation; Proteomic technologies; Regulation of protein function; Transcription factors

Indexed keywords

ACTIN; ADENYLATE CYCLASE; BIOLOGICAL MARKER; CATHEPSIN; CYCLIN D1; CYTOSKELETON PROTEIN; ENOYL COENZYME A HYDRATASE; EPIDERMAL GROWTH FACTOR RECEPTOR; FILAMIN; GLUTAMATE AMMONIA LIGASE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; HEAT SHOCK PROTEIN 27; MEMBRANE PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 4; PROTEIN TYROSINE KINASE; RAB7 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FRA 1; UBIQUITIN PROTEIN LIGASE E3; UBIQUITIN THIOLESTERASE;

BONE DEVELOPMENT; BONE REMODELING; CELL DIFFERENTIATION; CELL TYPE; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMAN; MASS SPECTROMETRY; MESENCHYMAL STEM CELL; MITOGENESIS; MOLECULAR BIOLOGY; NUCLEOTIDE SEQUENCE; OSSIFICATION; OSTEOBLAST; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

ANIMALS; BONE REMODELING; CELL DIFFERENTIATION; HUMANS; OSTEOBLASTS; PROTEOMICS;

EID: 33750611975     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/14789450.3.5.483     Document Type: Review

References (57)

1. Harada S, Rodan GA. Control of osteoblast function and regulation of bone mass. Nature 423, 349-355 (2003).
2. McGowan JA. Perspectives on the future of bone and joint diseases. J. Rheumatol. 67(Suppl.), 62-64 (2003).
3. Teitelbaum SL. Bone resorption by osteoclasts. Science 289, 1504-1508 (2000).
4. Peter SJ, Liang CR, Kim DJ, Widmer MS, Mikos AG. Osteoblastic phenotype of rat marrow stromal cells cultured in the presence of dexamethasone, β-glycerolphosphate, and L-ascorbic acid. J. Cell Biochem. 71, 55-62 (1998).
5. Marie PJ. The molecular genetics of bone formation: implications for therapeutic interventions in bone disorders. Am. J. Pharmacogenomics 1, 175-187 (2001).
6. Malaval L, Liu F, Roche P, Aubin JE. Kinetics of osteoprogenitor proliferation and osteoblast differentiation in vitro. J. Cell Biochem. 74, 616-627 (1999).
7. van Driel M, Pols HA, van Leeuwen JP. Osteoblast differentiation and control by vitamin D and vitamin D metabolites. Curr. Pharm. Des. 10, 2535-2555 (2004).
8. van Driel M, Koedam M, Buurman CJ et al. Evidence that both 1α,25-dihydroxyvitamin D(3) and 24-hydroxylated D(3) enhance human osteoblast differentiation and mineralization. J. Cell Biochem. (2006) [Epub ahead of print].
9. Weitzmann MN, Pacifici R. Estrogen deficiency and bone loss: an inflammatory tale. J. Clin. Invest. 116, 1186-1194 (2006).
10. O'Farrell PH. High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 250, 4007-4021 (1975).
11. Yates JR 3rd. Mass spectrometry and the age of the proteome. J. Mass Spectrom. 33, 1-19 (1998). Basic review on MS-based proteomics.
12. Shevchenko A, Chernushevich I, Ens W et al. Rapid 'de novo' peptide sequencing by a combination of nanoelectrospray, isotopic labeling and a quadrupole/time-of-flight mass spectrometer. Rapid Commun. Mass Spectrom. 11, 1015-1024 (1997).
13. Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature 422, 198-207 (2003). Comprehensive overview of contemporary proteomic technologies.
14. Unlu M, Morgan ME, Minden JS. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 18, 2071-2077 (1997). Detailed description of DIGE technique.
15. Santoni V, Molloy M, Rabilloud T. Membrane proteins and proteomics: un amour impossible? Electrophoresis 21, 1054-1070 (2000). Detailed overview of 2D-PAGE-based membrane proteomics.
16. Wu CC, Yates JR. The application of mass spectrometry to membrane proteomics. Nat. Biotechnol. 21, 262-267 (2003).
17. Blonder J, Conrads TP, Veenstra TD. Characterization and quantitation of membrane proteomes using multidimensional MS-based proteomic technologies. Expert Rev. Proteomics 1, 153-163 (2004). Comprehensive review of contemporary approaches employed for 2D liquid chromatography-MS/MS analysis of complex membrane protein mixtures.
18. Myung JK, Afjehi-Sadat L, Felizardo-Cabatic M, Slavc I, Lubec G. Expressional patterns of chaperones in ten human tumor cell lines. Proteome Sci. 2, 8 (2004).
19. Salasznyk RM, Westcott AM, Klees RF et al. Comparing the protein expression profiles of human mesenchymal stem cells and human osteoblasts using gene ontologies. Stem Cells Dev.14, 354-366 (2005).
20. Olkku A, Bodine PV, Linnala-Kankkunen A, Mahonen A. Glucocorticoids induce glutamine synthetase expression in human osteoblastic cells: a novel observation in bone. Bone 34, 320-329 (2004).
21. Spreafico A, Frediani B, Capperucci C et al. A proteomic study on human osteoblastic cells proliferation and differentiation. Proteomics 6, 3520-3532 (2006).
22. Link AJ, Eng J, Schieltz DM et al. Direct analysis of protein complexes using mass spectrometry. Nat. Biotechnol. 17, 676-682 (1999). Seminal publication describing the application of 2D LC-MS/MS.
23. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17, 994-999 (1999). Detailed description of ICAT labeling technique.
24. 18O labeling.
25. Ong SE, Blagoev B, Kratchmarova I et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 1, 376-386 (2002). Detailed description of SILAC labeling technique.
26. Blonder J, Yu LR, Radeva G et al. Combined chemical and enzymatic stable isotope labeling for quantitative profiling of detergent-insoluble membrane proteins isolated using Triton X-100 and Brij-96. J. Proteome Res. 5, 349-360 (2006). Detailed description of simultaneous 18O and cICAT labeling applied on a single membrane protein sample coupled with multidimensional LC-MS/MS.
27. Ishihama Y, Oda Y, Tabata T et al. Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol. Cell. Proteomics 4, 1265-1272 (2005). Description of label-free quantitative proteomic approach.
28. Han DK, Eng J, Zhou H, Aebersold R. Quantitative profiling of differentiation-induced microsomal proteins using isotope-coded affinity tags and mass spectrometry. Nat. Biotechnol. 19, 946-951 (2001).
29. Wu CC, MacCoss MJ, Howell KE, Yates JR. A method for the comprehensive proteomic analysis of membrane proteins. Nat. Biotechnol. 21, 532-538 (2003).
30. Blonder J, Terunuma A, Conrads TP et al. A proteomic characterization of the plasma membrane of human epidermis by high-throughput mass spectrometry. J. Invest. Dermatol. 3, 691-699 (2004).
31. Watarai H, Hinohara A, Nagafune J, Nakayama T, Taniguchi M, Yamaguchi Y. Plasma membrane-focused proteomics: dramatic changes in surface expression during the maturation of human dendritic cells. Proteomics 5, 4001-4011 (2005).
32. Fischer F, Wolters D, Rogner M, Poetsch A. Toward the complete membrane proteome: high coverage of integral membrane proteins through transmembrane peptide detection. Mol. Cell. Proteomics 5, 444-453 (2006).
33. Conrads KA, Yu LR, Lucas DA et al. Quantitative proteomic analysis of inorganic phosphate-induced murine MC3T3-E1 osteoblast cells. Electrophoresis 25, 1342-1352 (2004). Quantitative 2D LC-MS/MS analysis of inorganic phosphate induced OB differentiation.
34. Beck GR. Inorganic phosphate as a signaling molecule in osteoblast differentiation. J. Cell. Biochem. 90, 234-243 (2003). Comprehensive overview of the role of inorganic phosphate in OB differentiation.
35. Conrads KA, Yi M, Simpson KA et al. A combined proteome and microarray investigation of inorganic phosphate-induced pre-osteoblast cells. Mol. Cell. Proteomics 4, 1284-1296 (2005).
36. Salasznyk RM, Klees RF, Westcott AM, Vandenberg S, Bennett K, Plopper GE. Focusing of gene expression as the basis of stem cell differentiation. Stem Cells Dev. 14, 608-620 (2005).
37. Huber LA. Is proteomics heading in the wrong direction? Nat. Rev. Mol. Cell Biol. 4, 74-80 (2003).
38. Patterson SD, Aebersold RH. Proteomics: the first decade and beyond. Nat. Genet. 33(Suppl.), 311-323 (2003).
39. Jung E, Heller M, Sanchez JC, Hochstrasser DF. Proteomics meets cell biology: the establishment of subcellular proteomes. Electrophoresis 21, 3369-3377 (2000).
40. Rashid KA, Hevi S, Chen Y, Le Caherec F, Chuck SL. A proteomic approach identifies proteins in hepatocytes that bind nascent apolipoprotein B. J. Biol. Chem. 277, 22010-22017 (2002).
41. Pinkse MW, Uitto PM, Hilhorst MJ, Ooms B, Heck AJ. Selective isolation at the femtomole level of phosphopeptides from proteolytic digests using 2D-NanoLC-ESI-MS/MS and titanium oxide precolumns. Anal. Chem. 76, 3935-3943 (2004).
42. Salih E. Phosphoproteomics by mass spectrometry and classical protein chemistry approaches. Mass Spectrom. Rev. 24, 828-846 (2005). Detailed review of various approaches employed in contemporary functional phosphoproteomics.
43. Zhang H, Li XJ, Martin DB, Aebersold R. Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat. Biotechnol. 21, 660-666 (2003).
44. Xiong L, Andrews D, Regnier F. Comparative proteomics of glycoproteins based on lectin selection and isotope coding. J. Proteome Res. 2, 618-625 (2003).
45. Yates JR 3rd, Gilchrist A, Howell KE, Bergeron JJ. Proteomics of organelles and large cellular structures. Nat. Rev. Mol. Cell Biol. 6, 702-714 (2005). Comprehensive review of subcellular approaches used for qualitative and quantitative proteomic profiling.
46. Foster LJ, de Hoog CL, Mann M. Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors. Proc. Natl Acad. Sci. USA 100, 5813-5818 (2003).
47. Blonder J, Hale ML, Lucas DA et al. Proteomic analysis of detergent resistant membrane rafts. Electrophoresis 25, 1307-1318 (2004).
48. Blonder J, Hale ML, Chan KC et al. Quantitative profiling of the detergent-resistant membrane proteome of ι-b toxin induced vero cells. J. Proteome Res. 4, 523-531 (2005).
49. Marie PJ. Fibroblast growth factor signaling controlling osteoblast differentiation. Gene 316, 23-32 (2003).
50. Kratchmarova I, Blagoev B, Haack-Sorensen M, Kassem M, Mann M. Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science 308, 1472-1477 (2005). Functional quantitative proteomic investigation of the phosphoproteome of differentially induced mesenchymal stem cells.
51. Foster LJ, Zeemann PA, Li C, Mann M, Jensen ON, Kassem M. Differential expression profiling of membrane proteins by quantitative proteomics in a human mesenchymal stem cell line undergoing osteoblast differentiation. Stem Cells 23, 1367-1377 (2005).
52. Dreger M. Subcellular proteomics. Mass Spectrometry Reviews 22, 27-56 (2003).
53. Anderson HC, Garimella R, Tague SE. The role of matrix vesicles in growth plate development and biomineralization. Front Biosci. 10, 822-837 (2005). Comprehensive overview of the role of matrix vesicles during OB differentiation.
54. Xiao Z et al. Analysis of the extracellular matrix vesicle proteome in mineralizing murine osteoblasts. J. Cell Physiol. (2006) [In press]. First detailed proteomic investigation of MV proteome.
55. Johnson K, Moffa A, Chen Y, Pritzker K, Goding J, Terkeltaub R. Matrix vesicle plasma cell membrane glycoprotein-1 regulates mineralization by murine osteoblastic MC3T3 cells. J. Bone Miner. Res. 14, 883-892 (1999).
56. Ducy P, Schinke T, Karsenty G. The osteoblast: a sophisticated fibroblast under central surveillance. Science 289, 1501-1504 (2000).
57. Gillette JM, Nielsen-Preiss SM. The role of annexin 2 in osteoblastic mineralization. J. Cell Sci. 117, 441-449 (2004).